Jin‐Jie Yan

The Association Between the Development of Radiation Therapy, Image Technology, and Chemotherapy, and the Survival of Patients With Nasopharyngeal Carcinoma: A Cohort Study From 1990 to 2012

Xue-Song Sun, Sai‐Lan Liu, Mei-Juan Luo et al. · International Journal of Radiation Oncology*Biology*Physics · 2019 · 122 citations · Full text

Radiation Therapy of Recurrent Nasopharyngeal Carcinoma: Report on 219 patients

Jin‐Jie Yan, Y.-H. Hu, Xian Gu · Acta Radiologica Oncology · 1983 · 94 citations

Adaptive Radiotherapy, 5-Year Survival, Radiation Medicine +13

Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy response

Sai‐Lan Liu, Xue-Song Sun, Jin‐Jie Yan et al. · Radiotherapy and Oncology · 2019 · 64 citations

Medicine, Metronomic Therapy, Nasopharyngeal Carcinoma Patients +7

Ten-year outcomes of survival and toxicity for a phase III randomised trial of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma

Xiaoyun Li, Qiuyan Chen, Xuesong Sun et al. · European Journal of Cancer · 2019 · 53 citations

Radiation Therapy, Medicine, Phase Iii +8

Concurrent chemoradiotherapy followed by adjuvant cisplatin–gemcitabine versus cisplatin–fluorouracil chemotherapy for N2–3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial

Li‐Ting Liu, Huai Liu, Ying Huang et al. · The Lancet Oncology · 2023 · 37 citations

Concurrent Chemoradiotherapy, Health Sciences, Radiation Therapy +9